Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brownlee

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Kidney International. Supplement|September 21, 2000
The missing link: a single unifying mechanism for diabetic complicationsT Nishikawa, D Edelstein, M Brownlee
Diabetes|June 1, 1984
Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetesM Brownlee, H Vlassara, A Cerami
Diabetes|December 1, 1980
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatographyM Brownlee, H Vlassara, A Cerami
Diabetologia|September 1, 1982
Assessment of diabetic control by measurement of urinary glycopeptidesH Vlassara, M Brownlee, A Cerami
Diabetes|April 1, 1988
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivoH Vlassara, M Brownlee, A Cerami
Diabetes|September 1, 1985
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoproteinM Brownlee, H Vlassara, A Cerami
Diabetes|June 1, 1985
Recognition and uptake of human diabetic peripheral nerve myelin by macrophagesH Vlassara, M Brownlee, A Cerami
Diabetes Care|November 1, 1988
Role of advanced glycosylation products in complications of diabetesA Cerami, H Vlassara, M Brownlee
Diabetes|July 1, 1983
Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasminM Brownlee, H Vlassara, A Cerami
Diabetes|September 1, 1986
Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitusM Brownlee, H Vlassara, A Cerami
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Kidney International. Supplement|September 21, 2000
The missing link: a single unifying mechanism for diabetic complicationsT Nishikawa, D Edelstein, M Brownlee
Diabetes|June 1, 1984
Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetesM Brownlee, H Vlassara, A Cerami
Diabetes|December 1, 1980
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatographyM Brownlee, H Vlassara, A Cerami
Diabetologia|September 1, 1982
Assessment of diabetic control by measurement of urinary glycopeptidesH Vlassara, M Brownlee, A Cerami
Diabetes|April 1, 1988
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivoH Vlassara, M Brownlee, A Cerami
Diabetes|September 1, 1985
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoproteinM Brownlee, H Vlassara, A Cerami
Diabetes|June 1, 1985
Recognition and uptake of human diabetic peripheral nerve myelin by macrophagesH Vlassara, M Brownlee, A Cerami
Diabetes Care|November 1, 1988
Role of advanced glycosylation products in complications of diabetesA Cerami, H Vlassara, M Brownlee
Diabetes|July 1, 1983
Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasminM Brownlee, H Vlassara, A Cerami
Diabetes|September 1, 1986
Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitusM Brownlee, H Vlassara, A Cerami
Pageof 16